Atle Fund Management AB grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 6.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 78,169 shares of the biopharmaceutical company’s stock after buying an additional 5,004 shares during the period. Gilead Sciences accounts for about 3.4% of Atle Fund Management AB’s investment portfolio, making the stock its 10th biggest holding. Atle ...